Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

SPECTRAL DOMAIN OCT DOPPLER ASSESSES AQUEOUS OUTFLOW

Kagemann, Lawrence (2013) SPECTRAL DOMAIN OCT DOPPLER ASSESSES AQUEOUS OUTFLOW. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Primary Text

Download (17MB) | Preview

Abstract

Glaucoma is the second leading cause of blindness worldwide, affecting approximately 67 million people and costing the US healthcare system an estimated $2.5 billion annually. The greatest risk factor for the diagnosis and progression of glaucoma is high eye pressure. All glaucoma medications and procedures are designed to reduce eye pressure, slowing disease progression and preserving vision.

The eye’s aqueous humor nourishes avascular tissues in the anterior segment. It also maintains the eye’s geometry by pressurizing the globe, facilitating its ability to focus light on the retina. The balance between aqueous humor production and uptake is responsible for the pressure within the eye. Most glaucoma medications are designed to reduce pressure by increasing aqueous humor outflow, and surgeries are designed to enhance or bypass exiting outflow pathways. But, the effects of medications and procedures on a patient by patient basis on outflow remain speculative.

Here, techniques for the non-invasive direct mapping and measurement of aqueous humor outflow in the living human eye are proposed. Mapping provides morphometric insights and measurements of the components of the outflow system, while the flow technique is the first to provide direct measurements of outflow, free of the assumptions plaguing other modalities. “Virtual casting” of the outflow system yields 3D maps from which terminal branches are identified. Doppler measurements quantify velocity within those branches. Total aqueous humor outflow is determined by integrating calculated flow across all identified terminal branches. These technologies can be adapted to existing FDA approved OCT clinical scanners. Clinical application of these technologies may improve the management of glaucoma by reducing the time needed to determine and implement optimal therapeutic strategies, thereby preserving vision in glaucoma patients.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Kagemann, Lawrencelek19@pitt.eduLEK19
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairSchuman, Joel/Sschumanjs@upmc.edu
Committee MemberStetten, Georgestetten@andrew.cmu.edu
Committee MemberWollstein, Gadiwollsteing@upmc.edu
Committee MemberIshikawa, Hiroshiishikawah@upmc.edu
Committee MemberGaleotti, Johnjgaleotti@cmu.edu
Date: 12 June 2013
Date Type: Publication
Defense Date: 26 March 2012
Approval Date: 12 June 2012
Submission Date: 5 April 2012
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Number of Pages: 229
Institution: University of Pittsburgh
Schools and Programs: Swanson School of Engineering > Bioengineering
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: glaucoma, optical coherence tomography, aqueous humor outflow, Doppler
Date Deposited: 11 Sep 2013 05:00
Last Modified: 12 Jun 2017 05:15
URI: http://d-scholarship.pitt.edu/id/eprint/11712

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item